Ask a Question

User boardwallet1

Member for: 6 days (since Aug 19)
Type: Registered user
Full name:
Location:
Website: https://www.selleckchem.com/products/reversan.html
About: Oncofid-P-B: a manuscript strategy for BCG less competent carcinoma in situ (CIS) from the vesica: Outcomes of a prospective Western Multicentre study at 20 a few months coming from therapy commence.

Activity by boardwallet1

Score: 100 points (ranked #49)
Questions: 0
Answers: 0
Comments: 0
Voted on: 0 questions, 0 answers
Gave out: 0 up votes, 0 down votes
Received: 0 up votes, 0 down votes

Wall for boardwallet1

Please log in or register to post on this wall.
Snow Theme by Q2A Market
Powered by Question2Answer
...